Editor's Note — This Edition

The Medicare Glucagon-Like Peptide-1 (GLP-1) Bridge launched July 1 — three days ago. The first wave of client calls has begun. This edition covers what agents are learning in real time, what the prior authorization (PA) process looks like in practice, and which client situations are generating the most confusion.

It also covers H.R. 1. The largest Medicaid cuts in history are now moving through state capitals, and the October 1 deadline for dual-eligible clients is 83 days away. Most agents have not had this conversation with their affected clients yet.

The Axxess Strategy Team


1. The GLP-1 Bridge Is Live. Here Is What the First 30 Days Look Like.


Pull Quote “The clients calling about GLP-1 aren’t asking about pharmacology. They’re asking if their agent knows about this — and whether their agent called them first or they had to find out on their own.”

What’s working

The Bridge launched on schedule. The central processor (Humana) is accepting PA requests from prescribing providers. The $50 flat monthly copay is applying correctly at participating pharmacies for Wegovy, Zepbound (KwikPen formulation only), and Foundayo. The PA process functions as a provider-initiated process — clients do not submit PAs themselves, and neither do agents.

The agents who built the four-question reference sheet from Issue 2 are handling calls in under five minutes. The most common call type: a client who saw television coverage, read an article, or heard from their doctor and wants to know if they qualify.

Three client situations generating disproportionate confusion

Situation 1: The client whose preferred drug isn’t covered. Clients asking about Ozempic or Mounjaro are getting a “not covered” answer from their pharmacy — because both carry diabetes indications, not weight-loss indications, and are not part of the Bridge. The answer is clear: Ozempic and Mounjaro route through standard Part D formulary for diabetes treatment. The Bridge covers only weight-loss indicated drugs.

Situation 2: The client enrolled in a non-qualifying plan type. Clients in Programs of All-Inclusive Care for the Elderly (PACE) organizations, private fee-for-service (PFFS) plans, or employer group waiver plans (EGWPs) are ineligible for the Bridge. These clients need to hear this clearly before they present at a pharmacy and are turned away.

Situation 3: The client who believes their body mass index (BMI) no longer qualifies. The BMI-at-initiation rule means a client who started a GLP-1 in 2024 with a BMI of 37 and has since lost weight may still qualify — if their prescriber attests to the historical BMI. Clients who believe they’ve “lost the right to qualify” because the drug worked need this clarification.

The Quiet Shift The Bridge operates completely outside the standard Part D benefit — the $50 copay does not appear on the client’s Part D Explanation of Benefits (EOB). Clients will not see it in their normal plan documents. If a client calls asking why their plan “doesn’t show” the GLP-1 benefit, the answer is that it’s a separate federal program with a separate claims pathway — not a plan benefit. Agents who understand this handle the call in two minutes. Agents who don’t spend twenty trying to find something in the plan documents that isn’t there.

Axxess Perspective

Any agent who has not yet proactively contacted clients on GLP-1 therapy for weight loss should do so this week. The call has two purposes: confirming Bridge eligibility and confirming the client’s prescriber is initiating the PA process. A client who is eligible but whose prescriber doesn’t know about the Bridge is not enrolled. The agent who surfaces this for the prescriber — through the client — becomes irreplaceable.


2. H.R. 1 From the States: What the 2026 Legislative Sessions Mean for Your Dual-Eligible Clients

H.R. 1 enacted the largest Medicaid cuts in history in 2025. Now that most 2026 state legislative sessions have wrapped, the picture of how states are responding is coming into focus — and it is highly uneven. [Source: Center for Children and Families, Georgetown University, July 2026]

What H.R. 1 changes and when

  • October 1, 2026: Federal Medicaid eligibility will be narrowed for certain lawfully present non-citizen populations. Dual-eligible clients in these categories will lose Medicaid benefits beginning October 1. [Source: Justice in Aging, 2026]
  • January 2027: Certain lawfully present immigrants who lose Medicaid in October 2026 may also have their Medicare coverage terminated. [Source: Rheinhardt & Bray PC, 2026]
  • 2027 onward: National Medicaid work requirements take effect, adding eligibility verification requirements that may result in eligible clients being disenrolled through paperwork failures.

Approximately 12 million Americans are dually eligible for Medicare and Medicaid. Around 65 percent are age 65 or older. These are among the most complex clients in any agent’s book — and the ones most likely to call with questions about coverage changes.

Why this conversation belongs in the agent relationship

Dual-eligible clients are not always aware of their full dual-eligible status or the scope of benefits it provides. The agent who understands H.R. 1’s impact on their state’s Medicaid program — and can explain specifically which benefits may change and when — is providing a service no other advisor in that client’s life is providing.

Axxess Perspective: Three conversations before October 1

  1. Identify which dual-eligible clients may be in the affected non-citizen categories. Clients who are refugees, asylees, or hold Temporary Protected Status (TPS) are in the most immediately affected categories. [Source: Justice in Aging, 2026]
  2. Understand your state’s response. Is your state cutting optional Medicaid benefits, or maintaining coverage with state funds? The Georgetown Center for Children and Families tracks state-by-state responses at ccf.georgetown.edu.
  3. Refer to appropriate resources for affected clients. Agents cannot navigate Medicaid eligibility determinations on behalf of clients. The appropriate referral is to a local elder law attorney, a State Health Insurance Assistance Program (SHIP) counselor, or a Medicaid legal aid organization.


1. Work Requirements — 2027 Implementation Planning. H.R. 1’s Medicaid work requirements will take effect in 2027. When states implement new eligibility systems, errors happen. Dual-eligible clients who are exempt from work requirements may still receive incorrect notices. Agents with significant dual-eligible books should monitor state implementation announcements and prepare for a wave of confused client calls in early 2027.

2. AEP 2027 Benefit Releases — 30 Days Away. Carriers will begin releasing 2027 benefit information to agents in August. The agents who have completed their T65 pipeline work from Issues 3 and 4 enter August with a defined prospect list and the time to evaluate 2027 plans carefully.

3. Network Disruption — Mid-Year Update. The July 1 contract termination deadline that clustered several major hospital system disputes has passed. Agents should re-run provider network audits for any client whose primary hospital system was in dispute — Mayo Clinic/Humana and several UnitedHealthcare disputes had July deadlines.



Why we’re watching this:

Six numbers that frame the H.R. 1 and GLP-1 landscape heading into the fall.

H.R. 1 and Dual Eligibles

  • 12 million Americans dually eligible for Medicare and Medicaid [Source: Justice in Aging, 2026] → The largest, most complex segment of the Medicare book. Every agent has some.
  • October 1, 2026 — federal Medicaid eligibility narrows for certain non-citizen populations [Source: Justice in Aging, 2026] → 83 days. The conversation window for affected clients is closing.
  • 65% of dual-eligible individuals are age 65 or older → This is not a fringe population. It is a significant share of most agents’ senior books.

GLP-1 Bridge — First 30 Days

  • $50/month flat copay confirmed operational at launch → The program launched on schedule. The infrastructure is working.
  • Wegovy, Zepbound (KwikPen), Foundayo — confirmed covered drugs → Ozempic and Mounjaro remain outside the Bridge. Know this before the call.
  • BMI at initiation — the eligibility lookback clients don’t know about → Clients who lost weight on GLP-1 therapy may still qualify through their prescriber’s historical attestation.


1. Run a GLP-1 eligibility check on every client currently on weight-loss GLP-1 therapy. Any client taking Wegovy, Zepbound, or a weight-loss indicated GLP-1 who has not yet enrolled in the Bridge should be contacted this week. Confirm their plan type qualifies, confirm their prescriber knows about the PA process, and document the conversation in your CRM. The proactive call takes five minutes. The reactive call takes thirty.

2. Identify your dual-eligible clients and determine if any are in H.R. 1’s affected non-citizen categories. Review your book for clients who may be refugees, asylees, or hold TPS. These clients face Medicaid eligibility changes on October 1. Even if you cannot resolve their Medicaid situation, the agent who calls them first — before they receive a confusing government notice — is the agent they trust for the next decade.

3. Know your state’s H.R. 1 Medicaid response before October 1. Go to ccf.georgetown.edu and find your state’s status. Know whether your state is cutting optional Medicaid benefits before the client calls asking what they’re losing.